Table 3 Summary of pathology in two groups

From: The utility of simultaneous CT-guided localization for multiple pulmonary nodules using microcoil before video-assisted thoracic surgery

Pathologic process Incidence
Group A (n = 58) Group B (n = 221)
Malignant   
Invasive adenocarcinoma 16 (27.6%) 104 (47.1%)
Minimally invasive adenocarcinoma 15 (25.9%) 58 (26.2%)
Adenocarcinoma in situ 3 (5.2%) 10 (4.5%)
Squamous cell carcinoma 1 (1.7%) 1(0.5%)
Metastases 0 3 (1.4%)
Pulmonary carcinoid 2 (3.4%) 1(0.5%)
Benign   
Atypical adenomatous hyperplasia 6 (10.3%) 10 (4.5%)
Minute pulmonary meningothelial-like nodules 0 2 (0.9%)
Nodular lymphoid hyperplasia 3 (5.2%) 4 (1.8%)
Benign intraparenchymal lymph node 2 (3.4%) 4 (1.8%)
Localized pneumonitis 3 (5.2%) 13 (5.9%)
Cryptococcosis 2 (3.4%) 3 (1.4%)
Tuberculosis 0 2(0.9%)
Granulomas 2 (3.4%) 1(0.5%)
Sclerosing hemangioma 0 1 (0.5%)
Fibrotic nodule 3 (5.2%) 4 (1.8%)